PANORAMIC trial

PANORAMIC
Study typeplatform trial
DatesDec 2021 - ongoing
LocationsUnited Kingdom
Lead researcherChris Butler, Paul Little
FundingNational Institute for Health and Care Research (NIHR)

The PANORAMIC trial (short for Platform Adaptive Trial of Novel Antivirals for Early Treatment of COVID-19 in the Community) is a clinical trial in the United Kingdom testing the effectiveness of new antiviral drugs at the early stages of COVID-19 infections.[1][2][3] The study aims to find out if antivirals can prevent death and hospitalisation and help faster recovery for people aged over 50 and those at higher risk due to underlying health conditions.[4] The trial was launched in December 2021,[5] and had nearly 30,000 people enrolled as participants.[6]

  1. ^ "PANORAMIC". www.panoramictrial.org. Retrieved 16 March 2022.
  2. ^ "Thousands needed to try a new Covid antiviral treatment". BBC News. 25 January 2022. Retrieved 16 March 2022.
  3. ^ "Public urged to sign up to world-first COVID-19 antiviral study". GOV.UK. Retrieved 16 March 2022.
  4. ^ "Covid cost-cutting will put blinkers on our best Covid research". the Guardian. 21 February 2022. Retrieved 16 March 2022.
  5. ^ Pinching, John (22 February 2022). "PANORAMIC view of World's largest COVID study". PharmaTimes. Retrieved 16 March 2022.
  6. ^ "Homepage". www.panoramictrial.org. Retrieved 4 November 2024.